Prostate cancer: Targeted therapy shrank tumors up to 74 percent in cells in mice

Researchers have identified a potential target to treat an aggressive type of prostate cancer. The target, a gene called SPINK1, could be to prostate cancer what HER2 has become for breast cancer.